SLC2A3 and non-small cell lung carcinoma: Surprisingly, we found that, in contrast to drug-resistant cells, GLUT3 expression was higher in gemcitabine-sensitive NSCLC cells (Fig. 1K, left panel) and paclitaxel-sensitive MDA-MB-231 cells (Fig. 1L, left panel).